Evaluation of the Efficacy of Romiplostim in Management of Chemotherapy-Induced Thrombocytopenia in Indian Patients: A Retrospective Study

Evaluation of the Efficacy of Romiplostim in Management of Chemotherapy-Induced Thrombocytopenia in Indian Patients: A Retrospective Study

Saved in:

Bibliographic Details
Main Authors:	Vikas Talreja, Sangeeta Khatwani, Priyanka Subhagan
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd.
Series:	South Asian Journal of Cancer
Subjects:	cancer chemotherapy-induced thrombocytopenia malignancies romiplostim tumor
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0045-1809351
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Romiplostim in thrombocytopenia treatment after allogeneic bone marrow transplantation
by: I. A. Lisukov, et al.
Published: (2014-07-01)

Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim
by: Alessandro Pecci, et al.
Published: (2017-11-01)

Should thrombopoietin receptor agonists be used for chemotherapy-induced thrombocytopenia?
by: Hanny Al-Samkari
Published: (2025-07-01)

The Cost-Effectiveness of Avatrombopag Versus Eltrombopag and Romiplostim in the Treatment of Patients with Immune Thrombocytopenia in the UK
by: Nichola Cooper, et al.
Published: (2025-03-01)

Clinical experience with romiplostim
by: G. B. Kuchma, et al.
Published: (2014-07-01)

Observation on the efficacy of TPO receptor agonists and platelet transfusion in chemotherapy-induced thrombocytopenia in malignant tumors
by: Huan Hu, et al.
Published: (2025-01-01)

Comparative efficacy and safety of rhTPO, romiplostim, and eltrombopag in the treatment of pediatric primary immune thrombocytopenia: a systematic review and network meta-analysis
by: Xiaofang Zhang, et al.
Published: (2025-06-01)

Thrombopoietin Receptor Agonists in Treatment of Idiopathic Thrompocytopenic Purpura (Primary Immune Thrombocytopenia): Efficacy and Safety in Everyday Clinical Practice
by: II Zotova, et al.
Published: (2017-01-01)

Urogenital haemorrhage secondary to Babesia gibsoni induced immune thrombocytopenia and its management with combination of romiplostim and prednisolone in a dog
by: Nadima Khan, et al.
Published: (2025-06-01)

Results of long-term treatment with thrombopoietin receptor agonists of resistant primary immune thrombocytopenia
by: O. Yu. Vinogradova, et al.
Published: (2024-12-01)

Management of patients with immune thrombocytopenia in the Moscow region
by: S. G. Zakharov, et al.
Published: (2022-11-01)

Experience of 2<sup>nd</sup> line therapy with eltrombopag in patients with immune thrombocytopenia
by: S. G. Zakharov, et al.
Published: (2023-09-01)

Complications of thrombopoietin receptor agonists therapy in patients with immune thrombocytopenia
by: S. G. Zakharov, et al.
Published: (2024-04-01)

Impact of Thrombopoietin Receptor Agonists on Pathophysiology of Pediatric Immune Thrombocytopenia
by: Paschalis Evangelidis, et al.
Published: (2025-01-01)

A multicenter mixed-methods study on the effects of intermittent fasting in patients with immune thrombocytopenia receiving thrombopoietin receptor agonists
by: Mohamed A. Yassin, et al.
Published: (2025-02-01)

Effective treatment of refractory aplastic anemia with romiplostim after failure of multiple thrombopoietin receptor agonists: a single-center retrospective study
by: Xijuan Lin, et al.
Published: (2025-12-01)

PATIENTS WITH ≥ 20 X 109/L PLATELETS AT BASELINE MAY HAVE A PROMPT RESPONSE TO ROMIPLOSTIM DURING THE EARLY PHASE OF TREATMENT: AN ITALIAN SINGLE-INSTITUTION EXPERIENCE
by: Simone Baldini, et al.
Published: (2012-06-01)

Efficacy and safety of different treatments in chemotherapy-induced thrombocytopenia: a systematic review and network meta-analysis
by: Huiyan Yang, et al.
Published: (2025-07-01)

Initial Data on Clinical Use of Generic Romiplostim for Second-Line and Subsequent Therapy of Immune Thrombocytopenia in India
by: Suvir Singh, et al.
Published: (2021-01-01)

Effectiveness of partial splenic embolization in colorectal cancer patients with chemotherapy-induced thrombocytopenia: results of a single institution retrospective study
by: Dan Li, et al.
Published: (2024-10-01)

Experience of off-label use of Eltrombopag in the treatment of thrombocytopenia associated with solid tumors
by: María Henar García Lagunar, et al.
Published: (2015-02-01)

Correction of Thrombocytopenia before Elective Surgery / Invasive Procedures in Patients with Liver Cirrhosis (Experts’ Agreement)
by: M. V. Maevskaya, et al.
Published: (2024-08-01)

Thrombopoietin Receptor Agonists: Clinical Use and Evaluation of Treatment Efficacy
by: A. G. Solodovnikov, et al.
Published: (2020-12-01)

Potential of anticoagulant therapy in cardiology practice for thrombocytopenia. Literature review
by: K. G. Pereverzeva, et al.
Published: (2023-09-01)

Acquired angioedema and rituximab-induced acute thrombocytopenia in splenic marginal zone lymphoma
by: Odd Terje Brustugun, et al.
Published: (2025-07-01)

HEPARIN-INDUCED THROMBOCYTOPENIA IN PATIENT POST LIVER TRANSPLANTATION
by: M. Sh. Hubutija, et al.
Published: (2018-04-01)

SAFETY STUDY OF ROMIPLOSTIM BIOSIMILAR
by: A. N. Afanasyeva, et al.
Published: (2022-10-01)

COVID-19 vaccine-induced immune thrombotic thrombocytopenia
by: A. B. Sugraliyev, et al.
Published: (2022-06-01)

Experimental Validation a Method for Assessing Neutralizing Antibodies of Romiplostim in Human Plasma
by: A. N. Afanaseva, et al.
Published: (2024-03-01)

Clinical and Laboratory Analysis of Children Who Follow Up with Thrombocytopenia: A Retrospective Study
by: Yasemin Denkboy Öngen, et al.
Published: (2025-04-01)

Heparin-induced thrombocytopenia in a hemodialysis patient
by: YE Wei-xiang, et al.
Published: (2019-01-01)

Can you diagnose immune thrombocytopenia in myeloma? A case of thrombocytopenia in a patient with multiple myeloma
by: Cláudia Diogo, et al.
Published: (2024-11-01)

Understanding and Managing Thrombocytopenia in Pregnancy: A Case Series
by: Akshaya Radhakrishnan, et al.
Published: (2024-11-01)

Vaccine-induced immune thrombotic thrombocytopenia: definition, risks with different vaccines, and regulatory responses
by: S. V. Akinshina, et al.
Published: (2021-11-01)

The role of thrombopoietin receptor agonists in the management of adult primary immune thrombocytopenia: A single centre experience
by: Virijević Marijana, et al.
Published: (2022-01-01)

Immune thrombocytopenia in the aspect of multiple primary neoplasms
by: R. V. Vardanyan, et al.
Published: (2023-09-01)

Investigating thrombocytopenia in Meropenem-treated patients: a cross-sectional observational study
by: Ahmed E. Altyar, et al.
Published: (2025-07-01)

Ventricular septal rupture after acute myocardial infarction in a patient with venous thromboembolism complicated by thrombocytopenia: A case report
by: Yuansong Zhu, et al.
Published: (2023-03-01)

Thrombosis with thrombocytopenia after first dose of ChAdOx1 nCoV-19 vaccine: a case report
by: K. Kolodynskaja, et al.
Published: (2021-12-01)

Valproate-induced thrombocytopenia
by: N. V. Izmozherova, et al.
Published: (2024-04-01)